9th Annual NATA Symposium Scientific Program

Scientific Program

Thursday, April 3, 2008

MORNING

8:45-9:00 Welcome Address
Alice Maniatis, Athens, Greece

TRANSFUSION COMPLICATIONS

Marcela Contreras, London, UK
Gabriel de Olim, Lisbon, Portugal


9:00-9:20 Transfusion-Related Acute Lung Injury: Surveillance and Precautionary Measures
Sheila MacLennan, Leeds, UK

9:20-9:40 Effect of Leukodepletion on the Incidence of Post-Transfusion Purpura and Transfusion-Associated Graft-Versus-Host Disease
Catherine Chapman, Newcastle, UK

9:40-10:00 Pathogen Inactivation: Results of a Consensus Conference
Harvey G. Klein, Bethesda, MD, USA

10:00-10:20 Questions and Answers

10:20-10:50 Break


MANAGEMENT OF CHRONIC ANEMIA

Alice Maniatis, Athens, Greece
Ricardo Matos, Lisbon, Portugal


10:50-11:10 Anemia, Chronic Renal Disease and Chronic Heart Failure: the Cardio Renal Anemia Syndrome
Donald Silverberg, Tel Aviv, Israel

11:10-11:30 Erythropoiesis-Stimulating Agents vs. Blood Transfusion: Risk/Benefits Analysis in Oncology Patients
Rita Flemming, Lisbon, Portugal

11:30-11:50 Erythropoietin Therapy in Critically Ill Patients
Dean A. Fergusson, Ottawa, ON, Canada

11:50-12:10 Novel Erythropoiesis-Stimulating Agents
Iain Mcdougall, London, UK

12:10-12:30 Questions and Answers


TRANSFUSION PRACTICE

Dafydd Thomas, Swansea, Wales, UK
Fátima Nascimento, Lisbon, Portugal


10:50-11:10 Cost of Blood Transfusion at the Institutional Level
Axel Hofmann, Vienna, Austria

11:10-11:30 How Well Can Transfusion Requirements Be Predicted?
Giovanni Inghilleri, Milan, Italy

11:30-11:50 Do Transfusion Guidelines Help Reduce Transfusion?
Hans Gombotz, Linz, Austria

11:50-12:10 The Role of Blood Bank Doctor in Clinical Transfusion (ISBT Presentation)
Hans Erik Heier, Oslo, Norway

12:10-12:30 Questions and Answers


12:30-14:30 Lunch Break, Satellite Symposia


LUNCHTIME SATELLITE SYMPOSIUM: MANAGEMENT OF PREOPERATIVE ANEMIA IN ELECTIVE ORTHOPEDIC SURGERY – NATA GUIDELINES

Supported by an educational grant from Janssen-Cilag

Alice Maniatis, Athens, Greece
Peter Earnshaw, London, UK


12:30-12:35 Introduction
Alice Maniatis, Athens, Greece

12:35-12:45 Prevalence and Causes of Preoperative Anemia
Photis Beris, Geneva, Switzerland

12:45-12:55 Impact of Preoperative Anemia on Transfusion Requirements and Clinical Outcomes
Oliver Habler, Frankfurt, Germany

12:55-13:05 Clinical Significance of Postoperative Anemia
Göran Benoni, Malmö, Sweden

13:05-13:15 Preoperative Stimulation of Erythropoiesis Versus Preoperative Autologous Blood Transfusion
Peter Earnshaw, London, UK

13:15-13:25 Management of Preoperative Anemia in a Blood-Conservation Algorithm
Robert Slappendel, Nijmegen, The Netherlands

13:25-13:40 Detection and Evaluation of Preoperative Anemia and Iron Deficiency
Lawrence Tim Goodnough, Stanford, CA, USA

13:40-13:55 Management of Preoperative Anemia: Oral Iron, Intravenous Iron, Folic Acid, Vitamin B12
Alice Maniatis, Athens, Greece

13:55-14:10 Management of Preoperative Anemia: Recombinant Human Erythropoietin
Dean A. Fergusson, Ottawa, ON, Canada

14:10-14:30 Interactive Panel Discussion


LUNCHTIME SATELLITE SYMPOSIUM: BIOSIMILARS – CLINICAL AND REGULATORY PERSPECTIVES

Charles-Marc Samama, Paris, France


12:40-12:50 Introduction
Charles-Marc Samama, Paris, France

12:50-13:10 Biosimilars – A European Perspective
Margarida Menezes Ferreira, Lisbon, Portugal

13:10-13:30 Biosimilars – A North American Perspective
Lilia Talarico, Boston, MA, USA

13:30-13:50 Low-Molecular-Weight-Heparins – How Similar Are They?
Walter Jeske, Maywood, IL, USA

13:50-14:10 Biosimilar Low-Molecular-Weight-Heparins – A Regulatory Perspective
Mira Pavlovic, Saint-Denis, France

14:10-14:30 Interactive Panel Discussion


 

Thursday, April 3, 2008

AFTERNOON

THROMBOSIS

Jean-François Hardy, Montreal, QC, Canada
Margarida Amil, Porto, Portugal


14:30-14:50 Perioperative Management of New Anticoagulants
Charles-Marc Samama, Paris, France

14:50-15:10 Heparin-Induced Thrombocytopenia
Grigoris R. Gerotziafas, Paris, France

15:10-15:30 Activated Protein C – Do We Have the Answer?
Charles Natanson, Bethesda, MD, USA

15:30-16:00 Questions and Answers


INTRAVENOUS IRON

Photis Beris, Geneva, Switzerland
Manuel Quintana Diaz, Madrid, Spain


14:30-14:50 Intravenous Iron in Surgery
Manuel Muñoz, Málaga, Spain

14:50-15:10 Intravenous Iron in Obstetrics
Alice Maniatis, Athens, Greece

15:10-15:30 Iron Deficiency and Anemia in Inflammatory Bowel Disease
Christoph Gasche, Vienna, Austria

15:30-16:00 Questions and Answers

16:00-16:30 Break


ORAL COMMUNICATIONS (POSTER AWARDS)

Hans Gombotz, Linz, Austria
Philippe Van der Linden, Brussels, Belgium


16:30-16:45 E-learning is a Highly Efficacious Method for the Transmission of Hemovigilance Awareness – The Northern Ireland Experience
Annmarie McShane, Belfast, Northern Ireland

16:45-17:00 Association between Duration of Storage of Transfused Red Blood Cells and Morbidity and Mortality in the Critically Ill: Fiction or Reality?
Michael Piagnerelli, Brussels, Belgium

17:00-17:15 A Randomized Comparison of Transfusion Triggers in Elective Orthopedic Surgery Using Leukocyte-Depleted Red Blood Cells
Cynthia So-Osman, Leiden, The Netherlands

17:15-17:30 Preoperative Epoetin Alfa Injections versus Postoperative Autologous Shed Blood Retransfusion in Total Hip and Knee Arthroplasty: A Prospective Randomized Clinical Trial
Adrianus F. C. M. Moonen Sittard, The Netherlands

17:30-17:45 Frequency of Early Acute Post-Traumatic Coagulopathy upon Emergency Room Admission: An Analysis of 8,724 Patients from the German Trauma Registry
Marc Maegele, Cologne, Germany


SPECIAL LECTURE

Alice Maniatis, Athens, Greece


17:50-18:10 Celebrating NATA’s 10th Anniversary (1998-2008)
Jean-François Baron, Paris, France

18:15-18:45 NATA General Assembly


Friday, April 4, 2008

MORNING

TRANSFUSION TRIGGERS

Philippe Van der Linden, Brussels, Belgium
Harvey G. Klein, Bethesda, MD, USA

 
9:00-9:20 The SOAP Study – Do the Benefits of Transfusion Outweigh Its Risks?
Jean-Louis Vincent, Brussels, Belgium

9:20-9:40 Transfusion Triggers – What Evidence Do We Have?
Jean-François Hardy, Montreal, QC, Canada

9:40-10:00 Transfusion Trigger Design of Clinical Trials – The Pitfalls
Charles Natanson, Bethesda, MD, USA

10:00-10:30 Questions and Answers

10:30-11:00 Break


VOLUME REPLACEMENT

Oliver Habler, Frankfurt, Germany
Rui Araújo, Sto. António-Porto, Portugal

 
11:00-11:20 Outcome-Based Fluid Therapy
Andre Vercueil, London, UK

11:20-11:40 Fluid Resuscitation in Patients With Traumatic Brain Injury
John Myburgh, Sydney, Australia

11:40-12:00 Colloids in Septic Shock
Gernot Marx, Jena, Germany

12:00-12:30 Questions and Answers


PERIOPERATIVE BLEEDING

Charles-Marc Samama, Paris, France
Pedro Amorim, Porto, Portugal

 
11:00-11:20 Optimal Use of Point-of-Care Analyzers
Sibylle A. Kozek-Langenecker, Vienna, Austria

11:20-11:40 Safety of Prohemostatic Agents to Prevent or Treat Bleeding
Marcel Levi, Amsterdam, The Netherlands

11:40-12:00 Perioperative Bleeding: the Role of Factor XIII
Wolfgang Korte, St. Gallen, Switzerland

12:00-12:30 Questions and Answers

12:30-14:30 Lunch Break, Satellite Symposium


LUNCHTIME SATELLITE SYMPOSIUM: MANAGEMENT OF MAJOR INTRAOPERATIVE BLOOD LOSS

Supported by an educational grant from CSL Behring
Oliver Habler, Frankfurt, Germany

 
12:40-13:10 General Aspects
Oliver Habler, Frankfurt, Germany

13:10-13:40 Point-of-Care Monitoring of Coagulation
Klaus Görlinger, Essen, Germany

13:40-14:10 Specific Alterations of Coagulation in Trauma
Herbert Schöchl, Salzurg, Austria

14:10-14:30 Questions and Answers


LUNCHTIME SATELLITE SYMPOSIUM: FIBRIN SEALANTS: THEIR ROLE IN BLOOD-SPARING MANAGEMENT

Supported by an educational grant from Johnson & Johnson Wound Management

Marcela Contreras, London, UK
Peter Earnshaw, London, UK

 
12:30-12:35 Introduction

12:35-13:00 The Aprotinin Dilemma: Where Are We Now?
Heidi Doughty, Newcastle, UK

13:00-13:25 The Anesthetist and Perioperative Hemostasis
Dafydd Thomas, Swansea, Wales, UK

13:25-13:50 Improving Outcomes in Surgery
Peter Earnshaw, London, UK

13:50-14:30 Roundtable Discussion: What Strategies Should We Be adopting?

Moderated by Professor Marcela Contreras, London, UK
 

 

Friday, April 4, 2008

AFTERNOON

OXYGEN CARRIERS

Konrad Messmer, Munich, Germany
Manuel Algora Weber, Madrid, Spain

 
14:30-14:50 Criteria for Oxygen Carriers: Effects in the Microcirculation
Marcos Intaglietta, La Jolla, CA, USA

14:50-15:10 Perfluocarbon Emulsions
Pedro Cabrales, La Jolla, CA, USA

15:10-15:30 MP4 – Soon Ready for Clinical Use?
Philippe Van der Linden, Brussels, Belgium

15:30-16:00 Questions and Answers


TRANSFUSION ALTERNATIVES IN ORTHOPEDIC SURGERY

Manuel Muñoz, Málaga, Spain
Lucindo Ormonde, Lisbon, Portugal

 
14:30-14:50 Tranexamic Acid
Göran Benoni, Malmö, Sweden

14:50-15:10 Fibrin Sealants and Platelets Gels
Peter Earnshaw, London, UK

15:10-15:30 Blood Salvage
Dafydd Thomas, Swansea, Wales, UK

15:30-16:00 Questions and Answers

16:00-16:30 Break


SPECIAL LECTURE

Philippe Van der Linden, Brussels, Belgium
Jean-François Hardy, Montreal, QC, Canada

 
16:30-17:00 Aprotinin: Where Do We Stand?
Dean A. Fergusson, Ottawa, ON, Canada

17:00-17:30 Questions and Answers


17:30 Concluding Comments
Alice Maniatis, Athens, Greece